Abstract:BACKGROUND: Tongxinluo has been clinically proven to be effective in improving memory and cognitive function in patients with post-stroke vascular dementia. Is the mechanism related to the deposition of beta-amyloid peptide (A beta) in hippocampus?OBJECTIVE: To observe the effect of Tongxinluo on cognitive impairement in a mouse model with vascular dementia and the changes of A beta deposition and beta-secretase 1 (BACE I) expression. University Medical School, dementia and the changes of A beta deposition and beta-secretase 1(BACE I) expression.DESIGN: Randomized controlled studySETTING: State key Laboratory of Pharmaceutical Biotechnology of Nanjing University and Affiliated Drum Tower Hospital of Nanjing University Medical School.MATERIALS: The experiment was carried out in the State Key Laboratory of Pharmaceutical Biotechnology of Nanjing Universitv and Affiliated Drum Tower Hospital of Nanjing University Medical Jiangsu Province, No. School from March 2006 to January 2007. A total of 36 healthy Kunming mice. 18 of each gender were chosen. The study was conducted in accordance with the National Regulations of Experimental Animal Administration of Nanjing University. Tongxinluo was provided by Shijiazhunag Yiling Pharmaceutical Co. Ltd.METHODS: All mice were randomly divided into 6 groups, including naive control (n=6) sham-operated control (n=6) and experimental groups treated with different doses of Tongxinluo (0.2,0.4 and 0.6 g/kg/d: n=6 for each group) or vehicle (n=6). Five groups were subjected to bilateral common carotid arteries (2-VO) occlusion to produce a vascular dementia model (no occulsion was performed in sham-operated). The mice in the Tongxinluo treatment groups were intragastriely administered an equal volume of distilled water.MAIN OUTCOME MEASURES: 1 Escape latency time determined in all groups of mice before and after 2-VO occlusion by Morris water maze. 2 Changes in BACEI and A beta protein expression in the hippocampi of mice by Western blot.RESULTS: All 36 mice were involved in the final analysis. 1 No difference was detected in escape latency time to a hidden platform among all groups in water maze test before surgery (P > 0.05). At 30 days after 2-VO occlusion, the vehicle animals exhibited a significantly longer latency in finding the hidden platform compared to that of sham-operated and naive animals (P< 0.01). The prolonged escape latency was significantly reduced by oral administration of 0.4 g or 0.6 kg/day (P < 0.01,P < 0.05).BACEI mRNA and protein expression in vehicle animals were much higher than in sham-operated and naive animals (P < 0.01). The ischemia-induced increases in BACEI mRNA and protein level were attentuated by all three doses of Tongxinluo treatment (P < 0.01).2-VO occlusion were much higher than in sham-operated and naive animals (P < 0.01). 2-VO occlusion-induced A beta generation was significantly attentuated by all doses of Tongxinluo treatment, with the most effective dose being 0.4 g/kg/d (P<0.01).CONCLUSION: BACEI mRNA levels and protein levels of BACEI and A beta are reduced in the hippocampi of vascular dementia model mice by all three doses of Tongxinluo treatment, with the most effective dose being 0.4 g/kg/d. The results suggest that inhibition of post-ischemia BACEI expression and A beta generation in brain might underlie Tongxinluo's effects in improving cognitive impairement.

P3‐046: jingzhaotoxin‐v, a novel neurotoxin from spider chilobrachys jingzhao, rescues beta‐amyloid oligomers’ inhibition of long‐term potentiation and spatial learning and memory behavior

A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.

Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]

Neurochemical Mechanisms of a Novel Alzheimer′s Disease Therapeutics on Improvement of Cognition and Depressive Behavior

Improving Cognitive Impairment by Tongxinluo Via Inhibiting Expression of Beta-Secretase 1/Beta-Amyloid Peptide in Experimental Vascular Dementia

P4‐231: the Vanadium (IV) Compound Ameliorates OBX‐induced Neurodegeneration of the Septo‐hippocampal Cholinergic Neurons Through Akt and ERK Pathways

Neuroprotective Effect of Chinese Tarantula Chilobrachys Jingzhao Venom on Cerebral Ischemiareperfusion Injury in Mice

Xingnaojing ameliorates synaptic plasticity and memory deficits in an Aβ1–42 induced mouse model of Alzheimer's disease

Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial

Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis

Driving GABAergic neurons optogenetically improves learning, reduces amyloid load and enhances autophagy in a mouse model of Alzheimer's disease

DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice

Multifunctional Supramolecular Vesicles as Zn2+‐Triggered Microglial Modulator Alleviates Alzheimer's Disease

Tongxinluo Exerts Inhibitory Effects on Pyroptosis and Amyloid-β Peptide Accumulation after Cerebral Ischemia/Reperfusion in Rats.

Kaixin-San improves Aβ-induced synaptic plasticity inhibition by affecting the expression of regulation proteins associated with postsynaptic AMPAR expression

Effect of Tianzhi Particle on Ethology,and Intracerebral AchE and ChAT Activity in Rat with Vascular Dementia

Troriluzole rescues glutamatergic deficits, amyloid and tau pathology, and synaptic and memory impairments in 3xTg‐AD mice

Tetramethylpyrazine Derivative T-006 Ameliorates the Amyloid-β Plagues of Transgenic Alzhermer's Mice by Modulation of TLR4-mediated MyD88/NF-κB Signaling

Troriluzole Rescues Glutamatergic Deficits, Amyloid and Tau Pathology, and Synaptic and Memory Impairments in 3xTg-AD Mice

Riluzole ameliorates soluble Aβ1–42-induced impairments in spatial memory by modulating the glutamatergic/GABAergic balance in the dentate gyrus

NPLC0393 from Gynostemma pentaphyllum ameliorates Alzheimer's disease‐like pathology in mice by targeting protein phosphatase magnesium‐dependent 1A phosphatase